Gunnar Kratz

Karocell Tissue Engineering AB was started in 2001 based on research from the Karolinska Institute since the end of the 1980's. It was founded by Professor Gunnar Kratz and Doctor Anders Boman to further develop their ideas within culturing of cells and tissue engineering. Tissue engineering, which is one of the fastest growing areas in medicine today, applies the principles of biology and engineering to the development of functional substitutes for damaged tissues. The objective is to have the engineered tissue to become integrated with the patient's own tissue. This can be achieved either by culturing cells in vitro for transplantation as an auto transplant or by guiding cells in vivo to regeneration. Karocell's core operations are; production of autologous cells, and management of a skin bank and a cell bank.

Celltrix AB manufactures medical devices. It develops novel and injectable dermal filler for reconstructive cosmetic surgery, based on microbeads of cross-linked gelatine. The company was founded in December 2003 by Kjell Gösta Conny Nilsson and is headquartered in Malmö, Sweden.

Mölnlycke Health Care manufactures and markets single-use surgical and wound care products. The firm's surgical division offers surgical solutions through a range of single-use products that help minimize the risk of infections for patients, protect healthcare workers and increase the efficiency in the operating room. Its brands include: BARRIER, Biogel and HiBi. The company is headquartered in Gothenburg, Sweden.

Medicarb AB manufactures pharmaceutical products. It develops pharmaceuticals from biologically active carbohydrates and improves the performance of blood and tissue contacting medical devices with biocompatible coatings. The company was founded in 1983 and is headquartered in Bromma, Sweden.